Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration

Abstract

Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration.

What do Cochrane systematic reviews say about interventions for age-related macular degeneration?

“…The initial search retrieved 90 abstracts of systematic reviews (SRs), and 18 of them fulfilled our inclusion criteria and were considered for the analysis. [5][6][7][8][9][10][11][12][13][14][15][16][17][18][19][20][21][22] Results from systematic reviews…”

“…The 18 SRs included assessed the effects of surgical techniques (n = 4), 5-8 laser/photo/radiotherapy (n = 4), [9][10][11][12] intravitreal injections (n = 3), [13][14][15] systemic drugs (n = 3) [16][17][18] and phytotherapy/ vitamins/supplements (n = 4) [19][20][21][22] for preventing AMD or treating participants with AMD. The main results from the SRs that were included and the certainty of the evidence (based on the GRADE approach) 4 are presented in Table 2.…”

Impact of age‐related macular degeneration in patients with glaucoma: understanding the patients' perspective

“…These findings have important implications for clinicians, patients and policy makers. Macular evaluation, treatment of AMD 63,64 and optimisation of VA should be addressed appropriately to optimize and preserve glaucoma patients' participation in day-today tasks. Lifestyle-related risk factors associated with AMD should be discussed in newly diagnosed glaucoma patients in order to prevent these issues before they occur.…”

Les dispositifs informationnels sur les compléments alimentaires : une affaire de sante publique

“…La zéaxanthine, un pigment présent dans ces produits et censé prévenir la dégénérescence maculaire liée à l'âge (dmla), est fréquemment remplacée par de la méso-zéaxanthine une version de synthèse moins coûteuse. Ce constat est particulièrement dommageable pour ces compléments qui ont pourtant fait l'objet d'une méta-analyse dont la conclusion est en faveur d'effets positifs sur l'évolution de la dmla (Evans et al, 2012).…”